LAUREN AYCOCK: Open Payments
NPI 1821362385 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,944 in 130 payments from 15 companies in 2025. Trend: 2023 $1,406 · 2024 $1,687 · 2025 $1,944
Food & beverage: $1,944
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $371 |
| Regeneron Healthcare Solutions, Inc. | 11 | $283 |
| Novartis Pharmaceuticals Corporation | 29 | $236 |
| Galderma Laboratories, L.P. | 11 | $234 |
| GENZYME CORPORATION | 8 | $176 |
| UCB, Inc. | 12 | $165 |
| Janssen Biotech, Inc. | 9 | $153 |
| Amgen Inc. | 5 | $86 |
| PFIZER INC. | 2 | $54 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
Products named: DUPIXENT, NEMLUVIO, COSENTYX, RINVOQ, SKYRIZI, Bimzelx, TREMFYA, OTEZLA.
Industry payments across MS — which companies pay providers there.
